Robak, Tadeusz <br/><br/>
Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial.  [electronic resource] 

 -  Blood  May 2007 
 - 3672-5 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2006-08-042929  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cladribine--administration & dosage<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Leukemia, Hairy Cell--complications<br/>Male<br/>Middle Aged<br/>Poland<br/>Prospective Studies<br/>Remission Induction<br/>Sepsis--etiology<br/>Survival Rate